Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

COMIRNATY DIN 02541858

Status: Marketed
Holder: BIONTECH MANUFACTURING GMBH
Molecule: *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER

Health Canada record

Active ingredient(s)*SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER 10 MCG
Dosage formSuspension
RouteIntramuscular
ScheduleSCHEDULE D
ClassHuman
ATCJ07BN01 COVID-19, RNA-BASED VACCINE
Original market date23-Oct-2023
Current status date03-Sep-2025
SourceHealth Canada DPD

Establishment licence of the holder

BioNTech Manufacturing Marburg GmbH — licence , not currently licensed, last inspection rating C (2024-09-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER

DINProductCompanyFormStrengthStatus
02541823COMIRNATYBIONTECH MANUFACTURING GMBHSuspension*SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER 30 MCGMarketed
02552035COMIRNATYBIONTECH MANUFACTURING GMBHSuspension*SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER 30 MCGMarketed
02552078COMIRNATYBIONTECH MANUFACTURING GMBHSuspension*SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER 3 MCGApproved

Notices of Compliance

NOCDateSubmissionReason
318092023-09-28New Drug Submission (NDS)
Request a quote for COMIRNATY

How to read a Canadian DIN record